LOUISVILLE, Ky. / Aug 28, 2024 / Business Wire / CenterWell Home Health, one of America’s largest home health providers, has launched its 20th annual Food Fundraising Drive, an effort to fight food insecurity in the communities it serves.
Through Sept. 21, CenterWell Home Health branches across the country will be collecting food and funds to benefit local food banks in the 38 states it serves. CenterWell is also partnering with the national organization Feeding America to offer a single website to collect financial contributions from people wherever they are: CenterWell Home Health - Fundraising For Feeding America.
Over the years, CenterWell Home Health has collected and donated more than 1.3 million meals to people in need.
According to 2022 data from Feeding America, 7 million seniors aged 60+ are facing hunger because of food insecurity. That's 1 in 11 seniors, or 8.7% of all seniors.
“Food insecurity takes an especially heavy toll on seniors’ health and nutrition, increasing the risk of disease or worsening existing conditions,” said Sherri Rains, BSN, RN, CWOCN, Chief Clinical Officer for CenterWell Home Health. “As an organization dedicated to serving seniors, CenterWell Home Health knows firsthand the challenges they face. We want to ensure that food, the most basic component of good health, is available to all.”
About CenterWell
CenterWell is a leading health care services business focused on creating integrated and differentiated experiences that put our patients at the center of everything we do. The result is high quality health care that is accessible, comprehensive, and, most of all, personalized. As the largest provider of senior-focused primary care, one of the leading providers of home health care, and a leading integrated home delivery, specialty, hospice, and retail pharmacy, CenterWell is focused on whole health and addressing the physical, emotional and social wellness of our patients. CenterWell is part of Humana Inc. (NYSE: HUM). Learn more about what we offer at CenterWell.com.
| Last Trade: | US$260.28 |
| Daily Change: | 2.12 0.82 |
| Daily Volume: | 1,038,961 |
| Market Cap: | US$31.300B |
December 16, 2025 November 05, 2025 October 20, 2025 August 27, 2025 | |

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load